GCT President, Dr. Jeffrey Apter, joined the annual ECNP Congress in Barcelona, Spain this week. Being Europe’s premier scientific meeting for disease-oriented brain research, conference attracts neuroscientists, psychiatrists, neurologists and psychologists from around the world.

Participants discussed crucial aspects of psychoneurobiology, new advances in the therapy of psychotic disorders,  new findings in applied neuroscience and many other related topics.

GCT has a wide experience in CNS, effectively managing trials in Alzheimer’s disease, Multiple Sclerosis, and Epilepsy in CEE countries, Russia and India. We maintain strong and solid relationships with KOLs and have a huge database of high-recruiting investigative sites.

Please contact us at bd@gctrials.com to learn more!